Log in to save to my catalogue

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10263277

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

About this item

Full title

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

Publisher

Cham: Springer International Publishing

Journal title

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022-09, Vol.22 (5), p.567-575

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Digoxin is indicated for the management of heart failure with reduced ejection fraction and atrial fibrillation. Despite stronger guideline recommendations for other pharmacologic and device therapies, digoxin retains a role in select patients unable to tolerate or refractory to standard therapies. Contemporary utilization of and cost...

Alternative Titles

Full title

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10263277

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10263277

Other Identifiers

ISSN

1175-3277

E-ISSN

1179-187X

DOI

10.1007/s40256-022-00540-x

How to access this item